Vitrous Analysis in Proliferative Diabetic Retinopathy
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by St. Erik Eye Hospital.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Anders Kvanta, St. Erik Eye Hospital
First received: November 21, 2011
Last updated: June 5, 2012
Last verified: June 2012
Analysis of vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy
Proliferative Diabetic Retinopathy
||Observational Model: Cohort
Time Perspective: Prospective
||Analysis of Vitreous Proteins in Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy
Biospecimen Retention: Samples With DNA
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||December 2013 (Final data collection date for primary outcome measure)
To analyse and compare vitreous proteins in patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy.
|Ages Eligible for Study:
||12 Years and older
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Patients undergoing pars plana vitrectomy for proliferative diabetic retinopathy
- proliferative diabetic retinopathy with vitreous hemorrhage
- vitreous hemorrhage of other cause than proliferative diabetic retinopathy
- previous vitrectomy
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01478763
||Anders Kvanta, PhD
||St. Erik Eye Hospital
No publications provided
||Anders Kvanta, Professor, St. Erik Eye Hospital
History of Changes
|Other Study ID Numbers:
|Study First Received:
||November 21, 2011
||June 5, 2012
||Sweden: Regional Ethical Review Board
Keywords provided by St. Erik Eye Hospital:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on August 28, 2014
Endocrine System Diseases